High rates of heparanase in circulating lymphocytes have been associated with recurrence in breast cancer patients[38], and a decrease in plasmatic levels has also been associated with therapeutic response in children with Hodgkin lymphoma[39]. The gene discussed is HPSE; the disease is breast carcinoma.